Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Journal of Pharmaceutical Investigation is Scopus-indexed (Q1, CiteScore 10.6), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Springer.
Checked against the index lists dated .
ISSN 2093-5552Verify ISSN ↗2093-6214Verify ISSN ↗
Publisher: Springer
Cost to publish: About US$3,890 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | 3 / 57 | 95th | Q1 |
| Pharmaceutical Science | 20 / 191 | 89th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2012–present, best quartile Q1, CiteScore 10.6.
Journal of Pharmaceutical Investigation is Q1 in Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (rank 3 of 57) and Q1 in Pharmaceutical Science (rank 20 of 191), by CiteScore 2025.
Journal of Pharmaceutical Investigation is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 10.6, which places it in quartile Q1 at the 95th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.946, quartile Q1, with an H-index of 50.
The publisher lists an article processing charge of about US$3,890 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Journal of Pharmaceutical Investigation is published by Springer. Its print ISSN is 2093-5552 and its online ISSN is 2093-6214.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Journal of Pharmaceutical Investigation has an h-index of 59 and a 2-year mean of 6.09 citations per paper (OpenAlex). Its Scopus CiteScore is 10.6, quartile Q1. On 2-year citations it ranks #6 of 52 Scopus journals in Pharmacology, Toxicology and Pharmaceutics (miscellaneous).
Journal of Pharmaceutical Investigation published 82 papers in 2025; its busiest recent year was 2017 with 83. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2025–2026), authors are most often from South Korea (62.3%), United States (6.5%) and China (6%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 4 retracted papers are recorded (2.3 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.